BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 13, 2025
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
rHb1.1 phase I trials begin in end-stage renal disease
June 14, 1996
SC-55494 effective in combination with rhG-CSF
June 14, 1996
CCK-A agonists revealed by Glaxo Wellcome
June 14, 1996
Warner-Lambert seeks approval for atorvastatin
June 14, 1996
Monsanto reveals benzothiazepines with novel activity
June 14, 1996
ACAT inhibitors from Sankyo
June 14, 1996
Hyperlipidemia treatment from Takeda
June 14, 1996
Ligand/Wyeth-Ayerst collaboration extended
June 14, 1996
Phase I trial to begin for aerosolized form of osteoporosis drug
June 14, 1996
Sanofi Winthrop launches tiludronic acid
June 14, 1996
Previous
1
2
…
1747
1748
1749
1750
1751
1752
1753
1754
1755
…
1762
1763
Next
RSS